Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cotrimoxazole + metronidazole
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral, Intravenous
01
Overview
A combination of two distinct antibiotics. Cotrimoxazole (sulfamethoxazole/trimethoprim) is a broad-spectrum antibiotic effective against many bacterial infections, while metronidazole is a nitroimidazole antibiotic effective against anaerobic bacteria and certain parasites. This combination has been studied for prophylaxis in colorectal surgery and is commonly used in HIV/AIDS patients.
- Brand names
- BactrimSeptraFlagyl
- Other names
- co-trimoxazole + metronidazolesulfamethoxazole/trimethoprim + metronidazole
02
Targets
DHFR (Dihydrofolate reductase)NeuraminidaseDHPS (Dihydropteroate synthase)
Beyond the preview
Go deeper on cotrimoxazole + metronidazole.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cotrimoxazole + metronidazole.